Update on the Role of Cannabinoid Receptors after Ischemic Stroke
Cannabinoids are considered as key mediators in the pathophysiology of inflammatory diseases, including atherosclerosis. In particular, they have been shown to reduce the ischemic injury after acute cardiovascular events, such as acute myocardial infarction and ischemic stroke. These protective and...
Saved in:
Main Authors: | Luciano S. A. Capettini, Silvia Q. Savergnini, Rafaela F. da Silva, Nikos Stergiopulos, Robson A. S. Santos, François Mach, Fabrizio Montecucco |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/824093 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations
by: Fabrizio Montecucco, et al.
Published: (2012-01-01) -
Update in the Early Management and Reperfusion Strategies of Patients with Acute Ischemic Stroke
by: Aldo A. Mendez, et al.
Published: (2018-01-01) -
Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials
by: Mark Ware, et al.
Published: (2005-01-01) -
Role of Matrix Metalloproteinase-8 in Atherosclerosis
by: Sébastien Lenglet, et al.
Published: (2013-01-01) -
The Immune Response Is Involved in Atherosclerotic Plaque Calcification: Could the RANKL/RANK/OPG System Be a Marker of Plaque Instability?
by: Fabrizio Montecucco, et al.
Published: (2007-01-01)